Clickable Table

< back to the main pricing table
Generic Name Brand Name Strength Dosing 90 Day Cost Coverage Comments Category 1 Category 2
Empagliflozin Jardiance 10 mg, 25 mg QD $290 BC - SA / NIHB - Covered Hypoglycemic Agents Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors
Metformin Glucophage 500 mg 2 BID $25 BC / NIHB - Covered Hypoglycemic Agents Biguanides
Sitagliptin Januvia 100 mg QD $95 BC / NIHB - SA Hypoglycemic Agents Dipeptidylpeptidase-4 Inhibitors (DPP-4)
Liraglutide Victoza 1.2 mg SQ QD $745 BC / NIHB - NC Hypoglycemic Agents Glucagon-like Peptide 1 Agonist (GLP-1)
Rapid-acting insulin Novorapid 100 U/ml As dir $90 BC - NC / NIHB - SA Hypoglycemic Agents Insulin
Prices may vary between pharmacies, relative differences likely consistent. Max allowable price for 1500 Units of penfill insulin. Lantus, Novorapid, and Humalog part of Blue Cross biosimilar initiative so only biosimilar alternatives are covered (Basaglar, Trurapi, and Admelog, respectively).
Canagliflozin Invokana 100 mg QD $295 BC / NIHB - SA Hypoglycemic Agents Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors
Repaglinide Gluconorm 1 mg TID $40 BC / NIHB - Covered Hypoglycemic Agents Meglitinides
Liraglutide Victoza 1.8 mg SQ QD $1115 BC / NIHB - NC Hypoglycemic Agents Glucagon-like Peptide 1 Agonist (GLP-1)
Linagliptin Trajenta 5 mg QD $280 BC - SA / NIHB - Covered Hypoglycemic Agents Dipeptidylpeptidase-4 Inhibitors (DPP-4)
Semaglutide Ozempic 1 mg SQ Once weekly $540 BC / NIHB - SA Hypoglycemic Agents Glucagon-like Peptide 1 Agonist (GLP-1)
Basal insulin (Glargine) Toujeo 300 U/ml As dir $115 BC - NC / NIHB - Covered Hypoglycemic Agents Insulin
Prices may vary between pharmacies, relative differences likely consistent. Max allowable price for 1500 Units of penfill insulin. Lantus, Novorapid, and Humalog part of Blue Cross biosimilar initiative so only biosimilar alternatives are covered (Basaglar, Trurapi, and Admelog, respectively).
Gliclazide Diamicron 80 mg BID $35 BC / NIHB - Covered Hypoglycemic Agents Sulfonylureas
Metformin SR Glumetza SR 1000 mg 2 QD $290 BC - NC / NIHB - SA Hypoglycemic Agents Biguanides
Rapid-acting insulin biosimilars Trurapi 100 U/ml As dir $65 BC / NIHB - Covered Hypoglycemic Agents Insulin
Prices may vary between pharmacies, relative differences likely consistent. Max allowable price for 1500 Units of penfill insulin. Lantus, Novorapid, and Humalog part of Blue Cross biosimilar initiative so only biosimilar alternatives are covered (Basaglar, Trurapi, and Admelog, respectively).
Glyburide Diabeta 5 mg BID $25 BC / NIHB - Covered Hypoglycemic Agents Sulfonylureas
Dapagliflozin Propanediol Monohydrate Forxiga 10 mg QD $80 BC / NIHB - Covered Hypoglycemic Agents Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors
Basal insulin (Glargine) Lantus 100 U/ml As dir $120 BC - NC / NIHB - SA Hypoglycemic Agents Insulin
Prices may vary between pharmacies, relative differences likely consistent. Max allowable price for 1500 Units of penfill insulin. Lantus, Novorapid, and Humalog part of Blue Cross biosimilar initiative so only biosimilar alternatives are covered (Basaglar, Trurapi, and Admelog, respectively).
Rapid-acting insulin Apidra 100 U/ml As dir $75 BC / NIHB - Covered Hypoglycemic Agents Insulin
Prices may vary between pharmacies, relative differences likely consistent. Max allowable price for 1500 Units of penfill insulin. Lantus, Novorapid, and Humalog part of Blue Cross biosimilar initiative so only biosimilar alternatives are covered (Basaglar, Trurapi, and Admelog, respectively).
Gliclazide MR Diamicron MR 30 mg MR 2 QD $35 BC / NIHB - Covered Hypoglycemic Agents Sulfonylureas
Basal insulin (Degludec) Tresiba 100 U/ml As dir $140 BC / NIHB - Covered Hypoglycemic Agents Insulin
Prices may vary between pharmacies, relative differences likely consistent. Max allowable price for 1500 Units of penfill insulin. Lantus, Novorapid, and Humalog part of Blue Cross biosimilar initiative so only biosimilar alternatives are covered (Basaglar, Trurapi, and Admelog, respectively).
Rapid-acting insulin Humalog 100 U/ml As dir $100 BC - NC / NIHB - SA Hypoglycemic Agents Insulin
Prices may vary between pharmacies, relative differences likely consistent. Max allowable price for 1500 Units of penfill insulin. Lantus, Novorapid, and Humalog part of Blue Cross biosimilar initiative so only biosimilar alternatives are covered (Basaglar, Trurapi, and Admelog, respectively).
Rapid-acting insulin biosimilars Admelog 100 U/ml As dir $65 BC / NIHB - Covered Hypoglycemic Agents Insulin
Prices may vary between pharmacies, relative differences likely consistent. Max allowable price for 1500 Units of penfill insulin. Lantus, Novorapid, and Humalog part of Blue Cross biosimilar initiative so only biosimilar alternatives are covered (Basaglar, Trurapi, and Admelog, respectively).
Basal insulin biosimilar (Glargine) Basaglar 100 U/ml As dir $100 BC / NIHB - Covered Hypoglycemic Agents Insulin
Prices may vary between pharmacies, relative differences likely consistent. Max allowable price for 1500 Units of penfill insulin. Lantus, Novorapid, and Humalog part of Blue Cross biosimilar initiative so only biosimilar alternatives are covered (Basaglar, Trurapi, and Admelog, respectively).
Legend:
BC = Alberta Blue Cross, NIHB = Non-Insured Health Benefits for First Nations and Inuit, NC = Not covered, SA = special authorization